Immunoglobulin Replacement Therapy is critical and cost-effective in increasing life expectancy and quality of life in patients suffering from Common Variable Immunodeficiency Disorders (CVID): A health-economic assessment
Fig 2
Markov trace on mortality in the control and the intervention groups.
X-axis = cycle, from first to last (600). Y-axis = cumulative number of deaths. Dead_IgG = cumulative number of deaths in the intervention group (mean literature-based-dose IgGRT). Dead_Comp = cumulative number of deaths in the control group (zero-to-low-dose IgGRT).